U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 68

Tests names and labsConditionsGenes, analytes, and microbesMethods

COR120 - Comprehensive Pharmacogenetic Test

Quantigen Laboratory Quantigen LLC
United States
10810
  • T Targeted variant analysis

Cardio PGx Panel

Dynamic DNA Laboratories, LLC
United States
166
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Precision HealthPGx Panel (25 Genes)

RPRD Diagnostics, LLC
United States
9723
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Admera Health PGxOne™ Plus

Admera Health
United States
9916
  • T Targeted variant analysis

Whole Pharmacogenomics Scan

RPRD Diagnostics, LLC
United States
10769
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Comprehensive PGx Panel

Dynamic DNA Laboratories, LLC
United States
12518
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Gravity Pharmacogenetics Comprehensive Profile

Gravity Diagnostics
United States
8617
  • T Targeted variant analysis

Warfarin Response Genotype

Mayo Clinic Laboratories Mayo Clinic
United States
24
  • T Targeted variant analysis

CYP2C9 Genotype

Mayo Clinic Laboratories Mayo Clinic
United States
51
  • T Targeted variant analysis

Rxight Pharmacogenetics Program

MD Labs
United States
628
  • T Targeted variant analysis

Blood Coagulation Panel

Centogene AG - the Rare Disease Company
Germany
110112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CYP2C9, VKORC1 gene analysis

SPMED CO., LTD Step forward Personalized Medicine
South Korea
12
  • T Targeted variant analysis

PGx-Premium (Preemptive PGx test)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
6627
  • T Targeted variant analysis

PGx-Standard (Preemptive PGx test)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
3110
  • T Targeted variant analysis

Polypharmacy Comprehensive Panel

Invitae
United States
3324
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Warfarin sensitivity, 122700, Autosomal dominant (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Warfarin sensitivity, 122700, Autosomal dominant (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Tolbutamide poor metabolizer (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Tolbutamide poor metabolizer (CYP2C9 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

CYP2A6 (CYP2A6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 68

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.